Xiaodong Ma
Hefei, 230012, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Targeting conventionally intractable cancer-driving proteins: What has been achieved recently?
Journal: European journal of medicinal chemistry
Published: April 17, 2026
Targeting Telomerase Cajal Body Protein 1 (TCAB1) as a Novel Strategy for Discovering Potent Telomerase Inhibitors That Enhance Antitumor Immunity.
Journal: Journal of medicinal chemistry
Published: March 09, 2026
Discovery of SH-17 as a pioneering STAT3/HDAC bifunctional inhibitor that simultaneously impairs Tyr705 and Ser727 phosphorylation.
Journal: Bioorganic chemistry
Published: March 05, 2026
Targeted antibacterial and mesenchymal stem cell-modulatory hydrogel for periodontitis treatment.
Journal: Materials today. Bio
Published: December 10, 2025
Pyrazole carboxylic acid borneol esters: Novel neuroprotective agents with rapid, efficient brain penetration for the treatment of ischemic stroke.
Journal: European journal of medicinal chemistry
Published: November 26, 2025
Benzofuranyl-pyrazole as a Novel Scaffold for In Vitro and In Vivo Potent Anticancer Therapeutics That Directly Disrupt the 'Undruggable' MYC Oncogene and Potentiate Immune Checkpoint Blockage.
Journal: Journal of medicinal chemistry
Published: September 01, 2025
Novel 3-n-butylphthalide derivatives as potent multi-functional anti-IS agents with BBB protective function.
Journal: Bioorganic chemistry
Published: August 13, 2025
Smart Gated Hollow Mesoporous Silica Hydrogel for Targeting Endoplasmic Reticulum Stress and Promoting Periodontal Tissue Regeneration.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 09, 2025
Dual CDK6 and CDK9 inhibitors as anti-psoriasis agents: Design, synthesis, and anti-inflammatory activity.
Journal: Bioorganic & medicinal chemistry letters
Published: April 17, 2025
Successive structural optimization of Ziritaxestat culminates in the discovery of orally bioavailable and in vivo potent imidazothiadiazole derivative for treating ATX-driven diseases.
Journal: European journal of medicinal chemistry
Published: April 06, 2025
Effects of TGMXD-208, a Novel PI3K Inhibitor, on Adjuvant-induced Arthritis Rats by Suppressing PI3K/AKT Signaling Pathway
Journal: Endocrine, metabolic & immune disorders drug targets
Published: December 14, 2024
Last Updated: 09/26/2026